We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Follow-Up Study Investigates Progression of Vascular Plaque

By MedImaging International staff writers
Posted on 28 Jun 2017
Print article
Image: A new follow-up study will investigate the progression of vascular atherosclerotic plaque in patients from a previous study (Photo courtesy of Philips Healthcare).
Image: A new follow-up study will investigate the progression of vascular atherosclerotic plaque in patients from a previous study (Photo courtesy of Philips Healthcare).
A new large-scale study in the US that will investigate the progression of vascular atherosclerotic plaque in patients from a larger, previous study is slated to begin.

The new study will look at disease progression in at least 1,000 patients from a previous study that recruited 7,687 participants between the years 2008 and 2009. Researchers in the previous study used a novel ultrasound imaging method to identify atherosclerotic plaque disease in carotid arteries, and studied how this could affect the risk of the participants developing a heart attack or stroke.

The start of the new BioImage-2 study in Florida and Illinois was announced by the Mount Sinai Hospital (ISMMS; New York, NK, USA) and BioImage-2 (Lexington, MA, USA). The study will begin in September 2017 and continue for one year. The study is intended to promote research into carotid ultrasound imaging methods that can help clinicians decide how best to prevent heart attacks and strokes. The new study is intended to develop and test tools for bringing such imaging techniques into routine clinical practice and provide tailored preventive therapies.

Principal investigator of the BioImage-2 study, Director of Mount Sinai Heart, and Physician-in-Chief, Valentin Fuster, MD, said "Today a broad range of options exist for prevention of atherosclerotic vessel disease, which may lead to heart attack and stroke. If we can identify and characterize subclinical disease early and monitor this over the years, this may one day help us to better identify those who stand to gain most from the intensive preventive therapy options now available."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Software
UltraExtend NX
MRI System
uMR 588
New
Ultrasound Doppler System
Doppler BT-200

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.